Men incurring coronary heart disease (CHD) during surveillance of an employed population were studied for risk factors associated with additional myocardial infarctions. The coronaryprone Type A behavior pattern measured by a test score, number of cigarettes smoked daily, and serum cholesterol were significant discriminators between the 67 men with recurrent CHD and the 220 with but a single clinical CHD event. Diastolic blood pressure and fasting serum triglycerides were not significant discriminators. Statistical analyses directed to possible sources of bias occasioned by the combined retrospective-prospective study design revealed STRATEGIES FOR PRIMARY PREVENTION of coronary disease are built upon epidemiological studies which have confirmed that certain risk factors are predictive of the later emergence of clinical coronary heart disease (CHD). The best established of these risk factors include age, blood pressure, serum cholesterol, cigarette smoking, diabetes, and the family history of premature CHD.1 An additional risk factor, the coronary-prone behavior pattern, Type A, has shown a strong association with CHD in the few studies in which it has been included.2' 3 Type A behavior is characterized by excesses of being hard-driving, competitive, conscientious, hurried, impatient, aggressive, and striving for vocational and social achievement. More comprehensive descriptions appear elsewhere.4
that these problems are negligible and do not alter the findings observed. Type A score appears relatively unaffected by whether the measure was made before or after the initial CHD event. Multivariable discriminant function equations showed Type A score to be the strongest single predictor of recurrent CHD among the variables available. Number of cigarettes smoked and serum cholesterol accounted for additional variance. Future field trials for the secondary prevention of myocardial infarction would be strengthened by consideration of the possible role of Type A behavior.
ticipants in the study that year but, of course, excluded those relatively few subjects who had dropped out of the study before 1965 for any reason. Seventy-four percent of CHD cases occurring in the entire WCGS before the year of the test and 95% of the cases after the test completed the JAS in 1965. The cohort included 109 men who had developed CHD before entering the WCGS and 93 additional men whose clinical CHD emerged after entry into the WCGS but before taking the JAS in 1965. Ninety-four men developed CHD after taking the JAS but before January 1969. An additional 26 men developed CHD during 1969 and were reported in a prior prospective study,3 but are not included in this report because their period of risk for reinfarction was less than one year. In addition, the nine men whose first myocardial infarction was fatal were excluded from comparisons. The time relationships between entrance into the study, administration of the JAS, initial CHD diagnosis and second CHD event (a myocardial infarction) are shown in table 1. The statistical analyses in this report contrast the 220 men who survived their first CHD event and lived without reinfarction throughout the entire follow-up period ending in December 1969, with the 67 men who sustained a new myocardial infarction after their initial CHD event.
Methods
The diagnosis of CHD in the WCGS was made by an independent medical referee as previously described. 8 Myocardial infarction was diagnosed from the ECG on the basis of classic Q-wave patterns. These were supplemented by detailed inquiry from attending physicians and by hospital data in the large majority of instances of acute infarction. Where evidence of classic Q-wave changes was present on the ECG done at annual re-examination but no signs or symptoms had occurred sufficient to bring the subject to medical attention, a diagnosis of silent myocardial infarction was made. Angina pectoris (without infarction) was diagnosed by the medical referee adhering strictly to the criteria of Heberden. Any of these three presentations of CHD provided grounds for diagnosis of the initial CHD event. The diagnosis of a second or subsequent CHD event (recurrent infarction) was based on electrocardiographic evidence of a new infarction supported by appropriate NEW MYOCARDIAL INFARCTION/Jenkins, Zyzanski, Rosenman clinical evidence, often including serum enzyme changes and in the cases of sudden deaths, reports of witnesses and autopsy data. For the purposes of this study new episodes of silent myocardial infarction or exacerbations of angina pectoris were not considered recurrent CHD events.
Data for other CHD risk factors were derived from the annual WCGS re-examinations. Diastolic blood pressure and report of cigarette usage were obtained in 1965, simultaneously with the measurement of behavior type by questionnaire. Serum lipid determinations were not performed that year. The 1963 measures of serum cholesterol and serum triglycerides were closest in time and therefore selected for these analyses. In no instance were these risk factors measured while the patient was hospitalized. In most cases, measures were made after the patient had returned to work, thereby largely avoiding the temporary reductions in serum cholesterol and blood pressure which often follow an acute myocardial infarction. All decisions regarding the diagnosis of CHD were made in the absence of any knowledge of biological risk factors or behavior type scores.
The measurement of the coronary-prone behavior type was based on the 1965 edition of the Jenkins Activity Survey (JAS). This is a self-administered computer-processed 61item multiple choice questionnaire, the scores of which have been shown to agree 73% with the assessment of the coronary-prone behavior pattern derived from the structured interview."' The JAS Type A score has also been found associated with CHD prevalence'0 and incidence. 3 The four JAS scores reported here were derived without reference to medical diagnostic data. The Type A score was developed by discriminant function techniques to agree maximally with behavior type judgments based on the standard interview procedure.10 The remaining three JAS scales were derived by factor analysis." Each scale is standardized to have a mean of 0.0 and a standard deviation of 10.0 for the entire WCGS study group completing the test. Scores in the positive direction signify Type A behavior and scores in the negative direction indicate Type B behavior.
Results
Mean values of five commonly accepted risk factors for a first attack of CHD plus Activity Survey scores are presented in table 2 for 220 men having only a single CHD event and for those 67 with recurrent events. The table reveals that among the variables studied in these middleaged patients, the Type A score from the JAS, the number of cigarettes smoked per day and the level of serum cholesterol significantly distinguished the two clinical groups. All other variables included in the table showed trends in the direction of higher risk factors for the recurrent CHD group. These were not statistically significant despite the substantial sample sizes.
A point of criticism can correctly be raised that in some instances the risk factors were measured before one or both CHD events and in other instances after one or both CHD events. To examine whether this limitation of study design introduced bias into the results presented above, we stratified patients with recurrent CHD by whether their first CHD event occurred 1) before intake into WCGS, 2) after WCGS intake but before measurement of the risk factor, or 3) after measurement of the risk factor. The patients were tThis total excludes nine men whose first event was fatal and an additional 26 men who developed CHD in 1969 because their period at risk for new CHD events wvas less than one year. then cross-classified by whether their recurrent infarction came before or after measurement of the risk factor. This yielded a 3 X 2 classification table with one missing cell. Two-way nonorthogonal analyses of variance were computed with each risk factor as the dependent variable using the general linear models approach as described by Bock."2 Each analysis was computed to ascertain whether mean values of the risk factors differed significantly as a function of the timing of the initial attack (statistically eliminating the effect of the timing of the second attack), or a function of the timing of the second attack (statistically eliminating the effect of the timing of the first attack), or a function of some interaction of these two effects. The tables displaying these analyses are presented as Appendix 1 and 2. The results showed that in no instance were there significant differences between subgroups of patients as a function of the relative timing of their first or second CHD event and the measurement of any of the risk factors. The twelve P values generated range between .19 and .95. These findings justify combining all multiple event CHD cases into a single group for the statistical analyses presented in the other tables of this study. Patients having only one CHD event during the period of observation were stratified into three groups by the same time thresholds used for first events among recurrent cases. One-way analyses of variance revealed a trend for cases occurring after the risk factor measurement (i.e., prospective) to have somewhat higher means than cases occurring in the two periods before the measurement (i.e., retrospective) on number of cigarettes per day (means of 12.9 vs 9.5 and 8.9, P = 0.14) and on serum cholesterol (means of 247.7 vs 240.9 and 233.5, P = 0.09). Inconsequential differences were noted for diastolic blood pressure. (These means are displayed in the "No Recurrence" column of Appendix 1 and the results of the related statistical analysis are shown in Appendix 3.) The prospective single event cases tend to have marginally higher means on some risk factors and also a lower average number of years at risk in which to sustain reinfarction. This would tend to create a slight bias toward reducing the magnitude of mean risk factor differences if all single event cases had been combined and contrasted with all recurrent cases. We therefore performed two-way analyses of variance to test for the significance of the mean differences between single event and recurrent cases, eliminating by the second dimension of the design any effects which might be associated with timing of the initial event for both groups. These analyses are presented as Appendix 4 for cholesterol, diastolic blood pressure and number of cigarettes. These were shown in table 2 to manifest significant differences or marginal trends between single event and recurrent cases. The resulting F values and significance levels are virtually unchanged from the simpler analysis presented in table 2. The changes in probability level associated with the Fstatistics are as follows (the two-way analysis result is given second): for serum cholesterol, from .03 to .02; for cigarettes per day, from .02 to .01; for diastolic blood pressure, from .18 to .12.
The impact of a CHD event on behavior type, particularly on JAS score, has not been previously studied. Plausible arguments can be offered that the Type A score might change in either direction after hospitalization for clinical coronary disease. The impact upon Type A scores of the relative timing of single and recurrent CHD events and the taking of the JAS is examined in table 3.
Both for those cases having only a single coronary event and for those having recurrent coronary events mean Type A scores did not differ significantly as a function of whether the coronary events occurred before or after taking the JAS. There was a slight trend among men having only a single CHD event for Type A score to be lowest among cases farthest in the past and highest among men whose first CHD event was to occur in the near future. The three mean Type A scores in the lower part of table 3 are quite similar irrespective of the relation between time of taking the test and the clinical events. For neither the single nor the recurrent event categories was the overall value of the F-statistic significant for differences among temporal subgroups. Inasmuch as the three temporal groups within the single event and recurrent categories are statistically homogeneous, it is permissible to combine these groups as we have done in table 2 and in the analyses to follow. A two-way analysis of variance to eliminate such trend toward temporal effect as existed was computed for the Type A score in the same way as for other risk factors. (See Appendix 4.) The probability level associated with the difference between all single events vs all recurrent cases was virtually the same, changing only from P = 0.005 to P = 0.003.
Comparisons of Type A scores of these two clinical groups and a random sample of WCGS men remaining free of CHD revealed means of -0.60, 0.55, and 4.39 for those 524 men free of disease, 220 with only a single CHD event, and the 67 men with recurrent CHD, respectively. The analysis of variance F value of 7.83 (P = 0.001) indicates that these three means differ substantially. The comparison of magnitude of differences suggests that the JAS Type A score discriminates even more effectively between the recurrent and the single event groups than between the single event and the CHD-free population.
Prediction of Recurrent Myocardial Infarction from Multiple
Risk Factors The Type A score, age, and those risk factors shown in table 2 to be significantly associated with CHD recurrence were entered into a stepwise discriminant function computer program for the discrimination of nonrecurrent from recurrent CHD cases. The BMD program13 enters variables in the order of the strength of their independent contributions to correct discrimination between the two clinical groups. The results show how each variable contributes to the prediction of overall risk of recurrent MI independently of all the other variables already in the equation. For generation of classification tables a priori probabilities were set at .50 for each group. This tends to equalize misclassification rates for both groups even when the observed proportion of one may be smaller. Table 4 shows that Type A score, number of cigarettes smoked per day and serum cholesterol entered the prediction equation in that order, generating an equation which significantly discriminated recurrent from nonrecurrent cases. The classification table indicates that the equation correctly predicted 58% of both groups using the Type A score alone and improved this to 62% of single events and 63% of recurrences when the number of cigarettes smoked each day was added as a predictor. No further improvement occurred when serum cholesterol was entered. Its predictive power had been diminished by the prior entry of cigarette usage into the equation. These two variables correlated + .20 in this study group of 287 patients. Type A score was essen-344 CIRCULATION NEW MYOCARDIAL INFARCTION/Jenkins, Zyzanski, Rosenman tially uncorrelated with cigarettes and cholesterol (r = .00 and r = .02, respectively). The question can be raised whether the contribution of the Type A score is unique (perhaps a function of entering the equation first) or whether some combination of more standard risk factors entering the equation first can recombine in some way to predict recurrent CHD events nearly as well without its contribution. This is of particular importance for study groups of clinical populations for whom behavior type determinations are not available. In another discriminant function analysis, serum cholesterol, number of cigarettes smoked per day, diastolic blood pressure, and age were entered into the equation in the order of their strength. The latter two were forced in because of their established importance in prediction of initial CHD events despite their failure to make a statistically significant contribution in this analysis. Then the Type A score was allowed to enter as a fifth variable. The four-variable equation discriminated groups significantly at the P = 0.03 level F = 2.79 (df = 4,259) correctly assigning 59% of single events and 62% of recurrences. The Type A score entered the equation with an F value of 7.86 (df = 1,258, P = 0.01) which is slightly larger than when it entered the prediction equation in its natural order (in table 4 ). Type A score contributes only a minor improvement to the percentage of subjects correctly classified, however, as would be expected with the late addition of any factor to a list already containing several useful predictors.
In addition to the statistical regression approach, we also performed the simpler procedure of defining persons as high risk if they exceeded an accepted level for any significant risk factor. All patients in the study were stratified on the basis of whether their serum cholesterol was 260 mg/dl or greater; cigarette usage was 20 per day or greater; or Type A score was +5.0 or greater. For each risk factor about onethird of the total group was classified as high risk (34%, 34%, and 38% for cholesterol, cigarettes, and strong Type A, respectively). About 30% of the patients high on any given risk factor developed recurrent MI, but this also occurred to about 20% of the patients who were low risk by these criteria.
Discussion
This was a prognostic study of a group of men in the Western Collaborative Group Study8 who had entered the study with a diagnosis of clinical CHD or who had suffered one CHD event after intake. It sought to identify which risk factors were associated with recurrent CHD events. While the diagnosis of angina pectoris, clinically unrecognized in-farction, or acute myocardial infarction qualified a man for entry into this cohort of patients, only occurrence of a subsequent acute myocardial infarction was considered a recurrent CHD event for our purpose. Inclusion of angina patients without infarction is not likely to distort the prognostic findings inasmuch as Frank et al. 6 have found patients with angina pectoris to have a prognosis closely resembling that of patients with myocardial infarction. In the present study, a series of statistical analyses demonstrated that the combined retrospective-prospective nature of the relationship between risk factor measurements and CHD events did not introduce noticeable bias in evaluating the mean values of risk factors.
In this series of 220 men with single CHD events and 67 with recurrent events, three risk factors significantly distinguished between these two clinical groups: the Type A score from a self-administered test for this behavior pattern, number of cigarettes smoked per day, and serum cholesterol level. Prior studies finding Type A behavior to be associated with recurrence of CHD have been published by Rosenman et al."4 and by Jenkins et al.,'5 the former determining behavior type by a structured interview and the latter by a self-administered questionnaire (the JAS). The present study is an extension of these two earlier reports. It utilizes some of the same patients, but adds CHD events occurring in the final four years of the WCGS as explained earlier.
The first report of recurrent CHD in the WCGS'4 found that men ages 39-59 years at entry into the study who sustained recurrent CHD had significantly higher beta/alpha lipoprotein ratios, higher likelihood of arcus senilis, and higher cigarette usage. Higher serum cholesterol as well as a higher percent of Type A behavior pattern characterized the younger recurrent cases only (ages 39-49 years), whereas a higher diastolic blood pressure characterized older recurrent patients only (ages 50-59 years). The studies of prognosis in men with CHD conducted by the Health Insurance Plan of New York found higher blood pressures (by a complex criterion involving both systolic and diastolic blood pressure) to be associated with the probability of cardiac death, but no such association was observed for serum cholesterol.'6 The HIP also found that recurrence of myocardial infarction was associated with elevated blood pressures but not with cigarettes nor with serum cholesterol.
The recent findings from the Coronary Drug Project sponsored by the National Heart and Lung Institute'7 show that pharmacologic reduction of serum cholesterol levels does not significantly reduce reinfarction and CHD mortality. This is consistent with the HIP finding cited and with the earlier reports of Jones and others."' In contrast, the present study shows a significant association between cholesterol and risk of recurrent MI, a position supported by still other large-scale studies, for example that of Leren.19 All in all, this is a complex issue requiring further study. Cigarette usage was not a significant predictor in the HIP study as contrasted with this one. This may be because the HIP male population showed substantially higher average cigarette usage before their initial CHD event accompanied by a substantial reduction in smoking after this event, which persisted over four years.20 In WCGS, the reduction in smoking after the first clinical event was quite small.
Statistical analyses revealed that Type A scores appear to be relatively unbiased by whether the test is completed before or after a recent CHD event and that the scores are strongly associated with number of CHD events. Men with recurrent disease score substantially higher than those with one event or none at all. The factor analytically derived scores for separate components of the Type A pattern were not predictive of recurrent CHD, suggesting that it is the combination of behaviors represented in the clinically observed pattern that, at present, points most closely to the central nervous system phenomena which appear to link this behavior pattern to CHD risk.
Stepwise discriminant function procedures indicated for this series of CHD cases that among the variables available, the Type A score was the strongest single predictor of a new infarction and the number of cigarettes smoked per day made a further slight increase in the percentage of correct classification. It was further found that a nearly equivalent correct classification could be achieved through use of the variables serum cholesterol and number of cigarettes (with or without inclusion of age and diastolic blood pressure), with the addition of the Type A score making a further 3% increment in the strength of prediction. It appears that whichever of these three risk factors enters the equation first identifies most high risk people predictable by the entire set of variables. Each successive variable contributes diminishing improvements to the prediction.
The JAS Type A score thus appears to be a strong indicator of risk of new infarction in patients with a history of CHD. Only repeated studies in other clinical populations, however, can determine how generally the Type A score and other risk factors contribute incrementally to correct identification of patients at highest risk of recurrent CHD episodes. The risk factors found here to be important deserve serious consideration in future intervention studies aimed at improving the prognosis of heart disease patients.
A number of speculations exist regarding the mechanisms by which Type A behavior confers added risk of CHD. There is recent evidence that Type A is associated with increased atherosclerotic deposition in coronary arteries (unpublished observations), but whether this is also the mechanism accounting for the increased risk of reinfarction is not known.
Would intervention to diminish Type A behavior reduce risk of reinfarction in CHD patients? This is an important question, but to our knowledge no formal data presently exist which speak to this point. A controlled field trial could provide an answer, but initiation of such a study must await the demonstration of which methods can most effectively modify the Type A behavior pattern and whether a change can be sustained over long periods. It is our impression that neither education nor exhortation are sufficient to modify this deeply entrenched personal style, but that more intensive "therapies" are needed. The present study leaves many questions unanswered, but it underscores the importance of the research required to answer these questions. *Intake Retrospective cases are those whose first CHD event had occurred before intake into the WCGS in 1960-1961. tRecent Retrospective cases are those whose first CHD event occurred after intake into WCGS but before the risk factor measurement. Year of measurement is in parentheses after name of each risk factor. tProspective cases are those whose first CHD event occurred after the relevant risk factor measurement. 
